{
  "$type": "site.standard.document",
  "bskyPostRef": {
    "cid": "bafyreicqxfe6tf4jh46gecylc5m6bhnpoxx2iat2twuz73atqwcxo3fx6a",
    "uri": "at://did:plc:5ka4qkui7nvjms7idhte2m4o/app.bsky.feed.post/3mhvawaxr7si2"
  },
  "coverImage": {
    "$type": "blob",
    "ref": {
      "$link": "bafkreiezv3c3mg2nfyrxlcfyojhq3dfpr74is3iyyb6hddmjwtzwndz5vi"
    },
    "mimeType": "image/jpeg",
    "size": 64211
  },
  "path": "/2026/03/25/eli-lilly-glp1-merck-terns-pharma-readout-newsletter/?utm_campaign=rss",
  "publishedAt": "2026-03-25T13:25:35.000Z",
  "site": "https://www.statnews.com",
  "tags": [
    "Biotech",
    "Business",
    "Pharma",
    "The Readout",
    "biotechnology",
    "drug development",
    "research",
    "STAT+"
  ],
  "textContent": "Eli Lilly and the \"societal obligation\" of GLP-1s, Merck's Terns Pharma purchase, and more biotech news in today's Readout newsletter.",
  "title": "STAT+: Eli Lilly and the ‘societal obligation’ of GLP-1s",
  "updatedAt": "2026-03-25T13:25:39.000Z"
}